Despite AI’s potential in healthcare, major ethical concerns—like consent, transparency and responsibility—still surround the technology and its use in medicine. To address those concerns, Georgia researchers are encouraging physicians and healthcare companies to provide detailed information on AI systems to mitigate concerns patients may have with the technology. 

The Vanderbilt University Medical Center (VUMC) is looking to transform electronic health records (EHRs) by leveraging voice and AI technology to allow EHRs to naturally interact with physicians to find relevant information and hopefully enhance patient care.  

IBM Watson Health is partnering with the Broad Institute of MIT and Harvard to use AI and genomics to help clinicians better predict the onset of serious cardiovascular diseases, the company announced Feb. 13.

Researchers at West Virginia University (WVU) were awarded a $1 million grant from the National Institute of Justice to develop novel AI techniques to combat the opioid epidemic and opioid trafficking. The funding will be provided over a three-year period.

The Vatican and Microsoft are offering a nearly $7,000 prize for an international competition that aims to promote ethics in AI, according to a report by the Associated Press.

An NHS hospital in Scotland was honored by Microsoft during the HIMSS conference for its effort with KenSci to leverage AI and machine learning to reduce emergency hospital admissions among the highest risk chronic obstructive pulmonary disease (COPD) patients.

IBM Watson Health is investing $50 million over 10 years in a joint research collaboration with the Vanderbilt University Medical Center and Brigham and Women’s Hospital aimed at using AI to solve major public health issues.

President Trump will sign an executive order as part of the American AI Initiative to drive both the development and the regulations of AI, according to a report by The New York Times.

IBM is moving forward with a $2 billion expansion in New York to develop a new AI center, according to a report published in The Washington Post.

A recent win by DeepMind, an AI lab owned by Google parent company Alphabet, in a protein-folding problem competition has scientists wondering how the technology can change the drug discovery industry, according to a report by The New York Times.

Reuters reports the Trump administration will take executive action in the next few weeks to ensure the U.S. keeps abreast of research and development opportunities in “industries of the future”—including AI and 5G networks.

Researchers with MIT’s Computer Science and Artificial Intelligence Lab are working to develop an algorithm that can automatically “debias” data for AI models—an issue that has plagued the technology amid its growing prevalence in the medical field.